主页新闻资讯研究文献产业商业科研进展分类导航

|

产业动态

1,966 条内容

▶研究关注：Epitope Editing Strategy Could Enable Less Toxic Stem Cell Transplants2026-07-08
▶研究关注：Fujifilm Selected with Six Others in FDA PreCheck Pilot Manufacturing Program2026-07-08
▶研究关注：Interface Mismatches Remain Key Barrier to Continuous Bioprocessing2026-07-08
▶研究关注：Local PBMC Isolation Enables Four-Hour Processing in San Diego2026-07-08
▶研究关注：Plant Expression Platforms May Be Better Option for Biopharma in the Global South2026-07-08
▶研究关注：Perfusion Technologies Gain Momentum in Biomanufacturing2026-07-08
▶研究关注：Oligonucleotide Therapeutic Industry Readies Itself to Move to the Next Phase2026-07-08
▶研究关注：SEC reform good for life sciences startups, but getting pushback2026-07-08
▶研究关注：Phase II DMD Trailhead data hike Satellos’ stock2026-07-08
▶研究关注：Seres’ SER-155 takes on immune checkpoint inhibitor-related enterocolitis2026-07-08
▶研究关注：Appointments and advancements for July 8, 20262026-07-08
▶研究关注：Financings for July 8, 20262026-07-08
▶研究关注：Regulatory actions for July 8, 20262026-07-08
▶研究关注：In the clinic for July 8, 20262026-07-08
▶研究关注：Other news to note for July 8, 20262026-07-08
▶研究关注：Island Pharma targets Ebola species lacking approved treatments2026-07-08
▶研究关注：Astrazeneca nabs PDE3/4 inhibitor for COPD in $2.1B Sino deal2026-07-08
▶研究关注：AstraZeneca, GSK intensify China ties with Sino Biopharm deals2026-07-08
▶研究关注：Astrazeneca nabs PDE3/4 inhibitor for COPD in $2.1B Sino deal2026-07-08
▶研究关注：Astrocytes Preserve Memory Persistence Through Ankyrin-2 Protein in Mice2026-07-08
▶研究关注：Prime wins gene editing dispute; Saol claims latest post-Makary FDA reversal2026-07-08
▶研究关注：Beijing Jingwei-Yankang Biomedical divulges new RBP4 inhibitors2026-07-08
▶研究关注：ART-5 cleared for clinic in China for polycystic kidney disease2026-07-08
▶研究关注：Nurix Therapeutics patents new SMARCA2-targeting PROTACs2026-07-08
▶研究关注：FDA clears IND for LTZ Therapeutics’ LTZ-2322026-07-08
▶研究关注：CBP/p300 PROTAC degrader shows activity in multiple myeloma models2026-07-08
▶研究关注：Targeting VSIG4-high TAMs in colorectal cancer immunotherapy2026-07-08
▶研究关注：Coregen’s CRG-150 gains IND clearance for solid tumors2026-07-08
▶研究关注：Pikavation Therapeutics identifies new PI3Kα inhibitors2026-07-08
▶研究关注：KU Leuven and Universität Zürich describe new PTPN1/PTPN2 inhibitors2026-07-08
▶研究关注：Combo therapy reduces senescence, improves regeneration in mice2026-07-08
▶研究关注：FENS 2026: Shedding light on the sheddome2026-07-08
▶研究关注：Recombinant vaccine inhibits HBV-associated HCC growth2026-07-08
▶研究关注：Beijing Mabworks Biotech discloses new DLL3-targeting ADCs2026-07-08
▶研究关注：Microbial ecology reshapes cancer care, diagnostics and therapies2026-07-08
▶研究关注：Novartis to Acquire Myricx Bio for Up to $1.5B, Adding Cancer-Fighting ADC Payload Platform2026-07-08
▶研究关注：Germline‑Targeting HIV Vaccine Generates Broadly Neutralizing Antibodies in Primates2026-07-08
▶研究关注：Vertex Eyes Expansion Beyond Cystic Fibrosis with Planned $10B Crinetics Buyout2026-07-07
▶研究关注：AI Reveals Hidden Brain Lesions in Multiple Sclerosis MRI2026-07-07
▶研究关注：The Quest for Large-Scale DNA2026-07-07
▶研究关注：Biotech and Biomed Engineering Grad and Certificate Programs to Debut at Auburn2026-07-07
▶研究关注：Oberland pours up to $400M into MeiraGTx eye gene therapies2026-07-07
▶研究关注：340B reforms coming to the congressional table2026-07-07
▶研究关注：With tardy Tvardi phase I win, skin in STAT3 game plus GI2026-07-07
▶研究关注：Endocrinology becomes Vertex’s fifth pillar with $10B Crinetics buy2026-07-07
▶研究关注：Regulatory actions for July 7, 20262026-07-07
▶研究关注：Other news to note for July 7, 20262026-07-07
▶研究关注：In the clinic for July 7, 20262026-07-07
▶研究关注：Financings for July 7, 20262026-07-07
▶研究关注：Opus aligns with FDA on rare eye disease gene therapy trial2026-07-07
▶研究关注：Appointments and advancements for July 7, 20262026-07-07
▶研究关注：EG427 raises $37.7M series C for HSV gene therapy2026-07-07
▶研究关注：Vera’s Trutakna wins FDA nod as first dual inhibitor for IgAN2026-07-07
▶研究关注：Wuxi Apptec seeks immediate relief from US listing2026-07-07
▶研究关注：Some clinical trials in China under US congressional scrutiny2026-07-07
▶研究关注：Neuracle eyes Shanghai IPO as global BCI funding surges2026-07-07
▶研究关注：Behind China’s retractions, a paper-mill economy built on incentives2026-07-07
▶研究关注：Yes we Can-Fite PDAC; phase IIa results add momentum2026-07-07
▶研究关注：Bellaseno speeds breast scaffold trial as J&J deal clears path to market2026-07-07
▶研究关注：Science fiction realized: BCI tech is here2026-07-07
▶研究关注：China trial retractions put data transparency in spotlight2026-07-07
▶研究关注：Kailera says obesity pill succeeds in late-stage trial in China2026-07-07
▶研究关注：Bioprocessing at Full Throttle2026-07-07
▶研究关注：Vera’s Trutakna wins FDA nod as first dual inhibitor for IgAN2026-07-07
▶研究关注：AI Tackles Tuberculosis, Identifies Drugs that Penetrate Bacteria Membrane2026-07-07
▶研究关注：KLK1 Expands Possibilities to Restore Vascular Health2026-07-07
▶研究关注：A New Approach to Supporting Quality of Biologics2026-07-07
▶研究关注：A New Development Playbook for PROTACs2026-07-07
▶研究关注：Vertex to acquire Crinetics in $10B foray into endocrine disease drugs2026-07-07
▶研究关注：Astrazeneca returns to tap China’s CSPC in $1.7B discovery deal2026-07-07
▶研究关注：Mira reports results on optimized oral formulation of SKNY-12026-07-07
▶研究关注：Wigen Biomedicine Technology identifies new PI3Kα modulators2026-07-07
▶研究关注：STING agonists disclosed in Spark Biopharma patent2026-07-07
▶研究关注：MDC-134 enhances glucose-dependent β-cell insulin secretion2026-07-07
▶研究关注：China Pharmaceutical University discovers new PCSK9 inhibitors2026-07-07
▶研究关注：GDE4 blockade promotes remyelination, study finds2026-07-07
▶研究关注：Blood-based circRNAs for early detection and monitoring of Alzheimer’s2026-07-07
▶研究关注：AAVOlig001-ARSA shows promise in preclinical MLD study2026-07-07
▶研究关注：Astex Pharmaceuticals and Genentech collaborate in breast cancer2026-07-07
▶研究关注：Ono Pharmaceutical and Vanderbilt University detail new TREK1/2 inhibitor prodrugs2026-07-07
▶研究关注：Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads2026-07-07
▶研究关注：Gilead Sciences patents new TIPARP inhibitors2026-07-07
▶研究关注：‘Target-high but uptake-defective’ state identified in ADC resistance2026-07-07
▶研究关注：Biomanufacturing in Space to Be Key Topic at ISSCR 20262026-07-07
▶研究关注：HK biotech listings gain traction in Q2 with trio of June IPOs2026-07-07
▶研究关注：Appointments and advancements for July 7, 20262026-07-07
▶研究关注：Regulatory actions for July 7, 20262026-07-07
▶研究关注：In the clinic for July 7, 20262026-07-07
▶研究关注：Financings for July 7, 20262026-07-07
▶研究关注：Other news to note for July 7, 20262026-07-07
▶研究关注：Vera Therapeutics wins FDA nod for closely watched kidney disease drug2026-07-07
▶研究关注：New sa‑mRNA and LNP Platform to Support Korea’s Hantavirus Vaccine Initiative2026-07-07
▶研究关注：Unlocking Microbiome Function with Anaerobic Workflows and Metabolic Phenotyping2026-07-06
▶研究关注：Chimeric Allergen Receptor Treg Cells Suppress Allergic Asthma in Mice2026-07-06
▶研究关注：Pharma Races to Scale AI as Billions Flow into Drug Discovery2026-07-06
▶研究关注：Vertex buying Crinetics for $10B2026-07-06
▶研究关注：Regulatory actions for July 6, 20262026-07-06
▶研究关注：Appointments and advancements for July 6, 20262026-07-06
▶研究关注：In the clinic for July 6, 20262026-07-06
▶研究关注：Financings for July 6, 20262026-07-06
▶研究关注：Other news to note for July 6, 20262026-07-06
▶研究关注：CMS takes second run at lower reimbursement for 340B drugs2026-07-06
▶研究关注：Post-Tivdak, research in tissue factor multiplies2026-07-06
▶研究关注：Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads2026-07-06
▶研究关注：ICYMI: Week in review, June 29-July 3, 20262026-07-06
▶研究关注：Novartis to pay $1.5B for Myricx Bio and its novel ADC payloads2026-07-06
▶研究关注：Biggest gainers and losers for June 29-July 3, 20262026-07-06
▶研究关注：Gene editing developer Scribe plots an IPO2026-07-06
▶研究关注：ALS Drug Extends Survival in Mice, Targets TDP-43 Low-Complexity Domain2026-07-06
▶研究关注：Novartis to acquire ADC developer in a deal worth up to $1.5B2026-07-06
▶研究关注：Cancer, immune drugmakers dominate VC funding so far in 20262026-07-06
▶研究关注：Ascletis submits INDs for ASC-36 and ASC-36_35 for obesity2026-07-06
▶研究关注：Shanghai Aryl Pharmtech, Zhejiang Hisun report new CTPS1 inhibitors2026-07-06
▶研究关注：Beijing Double-Crane Runchuang identifies new TLR7/8 antagonists2026-07-06
▶研究关注：SET1B blockade as an approach in hepatocellular carcinoma2026-07-06
▶研究关注：New AR antagonist for mutated prostate cancer disclosed2026-07-06
▶研究关注：Astrazeneca returns to tap China’s CSPC in $1.7B discovery deal2026-07-06
▶研究关注：Chinese, Australian researchers disclose GD2 ganglioside-targeting ADCs2026-07-06
▶研究关注：Hyperexcitability may be joint problem in epilepsy, dementia2026-07-06
▶研究关注：Inventisbio patents new STAT6-targeting PROTAC compounds2026-07-06
▶研究关注：Genfleet Therapeutics synthesizes new PI3K inhibitors2026-07-06
▶研究关注：LAMP2A modulation regulates ovarian cancer response to platinum2026-07-06
▶研究关注：Novel ATR PROTAC shows strong antitumor efficacy2026-07-06
▶研究关注：VLA-4-targeted radiopharmaceutical enhances CAR T cells in neuroblastoma2026-07-06
▶研究关注：Beyond Boston: Unlikely cities stake biotech claims2026-07-06
▶研究关注：StockWatch: New UC Data Sparks Smoother Sailing for Abivax2026-07-05
▶研究关注：Holiday notice2026-07-05
▶研究关注：Behind China’s retractions, a paper-mill economy built on incentives2026-07-03
▶研究关注：Brightgene Bio-Medical discovers new calcitonin/AMY3 receptor agonists2026-07-03
▶研究关注：Brightpath files IND application for BP-2202 for multiple myeloma2026-07-03
▶研究关注：Beijing Avistone Pharmaceuticals prepares new KRAS mutant inhibitors2026-07-03
▶研究关注：Duke Street Bio reports new PARP-1 inhibitors2026-07-03
▶研究关注：Targeting FAM3D as a strategy against atherosclerosis2026-07-03
▶研究关注：Novel PGK1 inhibitor shows efficacy in pancreatic cancer models2026-07-03
▶研究关注：Insilico Medicine and Takeda collaborate on drug discovery2026-07-03
▶研究关注：FAK inhibitor tested in glioblastoma models2026-07-03
▶研究关注：NLRP3 inflammasome inhibitors disclosed in MSD patent2026-07-03
▶研究关注：CINP 2026: Prenatal and adolescent stress shape brain vulnerability2026-07-03
▶研究关注：University of Edinburgh patents new mTOR inhibitors2026-07-03
▶研究关注：Dual targeting of 17β-HSD10/CDK5 as disease-modifying approach in Alzheimer’s2026-07-03
▶研究关注：Synthetic Organizers Aid Creation of Reproducible Kidney Organoids from Stem Cells2026-07-02
▶研究关注：Elixirgen Builds Rare Disease Pipeline Around Telomere Biology Disorders and DMD2026-07-02
▶研究关注：Biopharma money raised: Jan. 1-July 2, 20262026-07-02
▶研究关注：Money raised by biopharma2026-07-02
▶研究关注：Merck and Insilico Make Deals, Claude Science’s Debut, Vaccines for Neglected Diseases2026-07-02
▶研究关注：ASMS 2026: Solving Proteomics’ Next Bottleneck2026-07-02
▶研究关注：Regulatory actions for July 2, 20262026-07-02
▶研究关注：Appointments and advancements for July 2, 20262026-07-02
▶研究关注：H1 2026 biopharma financings double from last year, approach pandemic highs2026-07-02
▶研究关注：Holiday notice2026-07-02
▶研究关注：In the clinic for July 2, 20262026-07-02
▶研究关注：Financings for July 2, 20262026-07-02
▶研究关注：Neuracle eyes Shanghai IPO as global BCI funding surges2026-07-02
▶研究关注：Behind China’s retractions, a paper-mill economy built on incentives2026-07-02
▶研究关注：Cell and gene therapy access is up, but capacity constraints may be looming2026-07-02
▶研究关注：Bellaseno speeds breast scaffold trial as J&J deal clears path to market2026-07-02
▶研究关注：Genentech’s KRAS G12C inhibitor divarasib shines in NSCLC phase III2026-07-02
▶研究关注：Wuxi Apptec seeks immediate relief from US listing2026-07-02
▶研究关注：Neurovalens brings FDA-cleared PTSD therapy to US veterans2026-07-02
▶研究关注：Other news to note for July 2, 20262026-07-02
▶研究关注：A PureTech startup banks $180M for a new IPF drug2026-07-02
▶研究关注：Genentech’s KRAS G12C inhibitor divarasib shines in NSCLC phase III2026-07-02
▶研究关注：Roche KRAS drug succeeds in head-to-head lung cancer study2026-07-02
▶研究关注：Ontrack Therapeutics divulges compounds for neurodegenerative diseases2026-07-02
▶研究关注：Reunion Neuroscience reports new 5-HT2A partial agonists and/or 5-HT2B antagonists2026-07-02
▶研究关注：Artan closes seed round to support tRNA platform2026-07-02
▶研究关注：Primo Thera synthesizes new IL-6Rβ inhibitors2026-07-02
▶研究关注：Triple-target antidepressant modulates neuroplasticity in vivo2026-07-02
▶研究关注：Ribocure and Madrigal nominate siRNA drug candidate for MASH2026-07-02
▶研究关注：Oral antiviral IRBM-Z-2 targets Zika infection2026-07-02
▶研究关注：Recurium patents new Wee1 inhibitors2026-07-02
▶研究关注：CLDN1 targeting suppresses CCA tumor growth2026-07-02
▶研究关注：Aigen Sciences discovers new USP1 inhibitors2026-07-02
▶研究关注：With GPNMB, CAR T makes further inroads in solid tumors2026-07-02
▶研究关注：Abera’s intranasal influenza vaccine shows promise in ferrets2026-07-02
▶研究关注：China trial retractions put data transparency in spotlight2026-07-02
▶研究关注：Peptistar Began Operation of the Asahi Kasei FO-MD System at Manufacturing Scale2026-07-02
▶研究关注：First 3D Structure of Malaria’s “Moving Junction” Solves Infection Mystery2026-07-01
▶研究关注：In Huntington’s Mouse, Optogenetic Activation of VIP Neurons Restores Brain Function2026-07-01
▶研究关注：Biological Order Emerges from Tissue Boundaries, Drives Embryo Development2026-07-01
▶研究关注：Digitize or Fall Behind2026-07-01
▶研究关注：Standardizing Personalized CRISPR Gene-Editing Therapies2026-07-01
▶研究关注：Blueprint to Fill the Manufacturing Talent Gap2026-07-01
▶研究关注：Trait Combining Key to More Effective Vector Production Hosts2026-07-01
▶研究关注：Other news to note for July 1, 20262026-07-01
▶研究关注：Appointments and advancements for July 1, 20262026-07-01
▶研究关注：Financings for July 1, 20262026-07-01
▶研究关注：In the clinic for July 1, 20262026-07-01
▶研究关注：Some clinical trials in China under US congressional scrutiny2026-07-01
▶研究关注：Regulatory actions for July 1, 20262026-07-01
▶研究关注：US primaries continue to rattle congressional health leadership2026-07-01
▶研究关注：Large VC financings improve in H1 20262026-07-01
▶研究关注：Follow-ons lead a mixed first half of 2026 for med-tech financing2026-07-01
▶研究关注：‘Cool move’ by Zimmer part of med-tech’s tuck-in deals trend2026-07-01
▶研究关注：Yes we Can-Fite PDAC; phase IIa results add momentum2026-07-01
▶研究关注：HK biotech listings gain traction in Q2 with trio of June IPOs2026-07-01
▶研究关注：In 2nd deal of week, Ipsen buys Memo’s kidney transplant antibody2026-07-01
▶研究关注：Orca’s T-cell therapy approach to HSCT wins FDA nod as Tregzi2026-07-01
▶研究关注：China trial retractions put data transparency in spotlight2026-07-01
▶研究关注：BridgeBio gets funding for drug launch; United buys into cell therapy2026-07-01
▶研究关注：Orca’s T-cell therapy approach to HSCT wins FDA nod as Tregzi2026-07-01
▶研究关注：Ipsen to buy Swiss biotech Memo Therapeutics in potential $800M deal2026-07-01
▶研究关注：5 FDA decisions to watch in the third quarter of 20262026-07-01
▶研究关注：Abivax shares surge as worries subside over immune drug’s cancer risk2026-07-01
▶研究关注：Bayer discovers new potassium channel blockers2026-07-01
▶研究关注：MED-EL acquires gene therapy programs from Rescue Hearing2026-07-01
▶研究关注：Flare Therapeutics to focus on AR-ON degrader FX-1112026-07-01
▶研究关注：Sun Pharmaceutical synthesizes new ATM kinase inhibitors2026-07-01
▶研究关注：SUCNR1 antagonist reverses tumor immune suppression2026-07-01
▶研究关注：Adlai Nortye discloses new KRAS G12C inhibitors2026-07-01
▶研究关注：Grant supports Aptevo’s immunotherapy APVO-451 for solid tumors2026-07-01
▶研究关注：Lab-grown retinal endothelial cells repair eye vasculature2026-07-01
▶研究关注：Telum Therapeutics advances antimicrobials with series A funding2026-07-01
▶研究关注：CINP 2026: organoids reveal autism and addiction mechanisms2026-07-01
▶研究关注：Shanghai Zheye Biotechnology patents new ApoA/APOB interaction inhibitors2026-07-01
▶研究关注：Targeting ENPP1 improves repair after acute kidney injury2026-07-01
▶研究关注：Trex Bio discloses TRB-071 as CD30 agonist antibody2026-07-01
▶研究关注：Monte Rosa Therapeutics divulges new CCNE1-targeting degraders2026-07-01
▶研究关注：Cytiva Completes Doubling of Utah Site’s Liquid Media Production Capacity2026-06-30
▶研究关注：Ipsen’s $450M blood cancer drug; FDA selects first cohort for “pre-check” pilot program2026-06-30
▶研究关注：Claude Science is Here, Antibiotics Designed by Text Prompt Among Applications2026-06-30
▶研究关注：iPSC-Derived Retinal Endothelial Cells Offer Platform for Studying Diseases2026-06-30
▶研究关注：Relaxed on Abivax: UC phase III cancer answer quells fretting2026-06-30
▶研究关注：FDA clears first flight of Precheck Rx manufacturing pilot2026-06-30
▶研究关注：NEJM paper on Tavneos pivotal trial retracted by academic authors2026-06-30
▶研究关注：Vistagen's SAD slump: lead pherine, fasedienol, fails again2026-06-30
▶研究关注：Deep brain stimulation from the shallows: tomorrow’s BCI technology?2026-06-30
▶研究关注：AI, data and wearables transforming health care, clinical trials2026-06-30
▶研究关注：Other news to note for June 30, 20262026-06-30
▶研究关注：Financings for June 30, 20262026-06-30
▶研究关注：Appointments and advancements for June 30, 20262026-06-30
▶研究关注：Regulatory actions for June 30, 20262026-06-30
▶研究关注：In the clinic for June 30, 20262026-06-30
▶研究关注：Corxel-Vincentage’s oral GLP-1 meets phase II obesity endpoints2026-06-30
▶研究关注：Lilly taps Abbisko for $1.9B discovery deal2026-06-30
▶研究关注：Otsuka’s centanafadine scores in ADHD, comorbid anxiety trial2026-06-30
▶研究关注：Samsung Bioepis’ Keytruda biosimilar hits phase I, III endpoints2026-06-30
▶研究关注：Nuvectis shares continue to rally after $1.46B Haisco deal2026-06-30
▶研究关注：High-profile retraction tests confidence in China-led studies2026-06-30
▶研究关注：Ollin’s $330M series B underscores rise of China-origin newco model2026-06-30
▶研究关注：Viridian may have edge over Amgen in eye drug showdown, analysts argue2026-06-30
▶研究关注：Deep brain stimulation from the shallows: tomorrow’s BCI technology?2026-06-30
▶研究关注：AI uncovers hidden antibiotic potential in prion proteins2026-06-30
▶研究关注：These biotechs just landed big fundraising hauls. Here’s what they pitched to investors.2026-06-30
▶研究关注：Beeline ups its Series A round for immune drug work2026-06-30
▶研究关注：Top FDA gene and cell therapy regulator to step down2026-06-30
▶研究关注：CINP 2026: Gut microbiota could predict antidepressant response2026-06-30
▶研究关注：Hexapharmatec identifies new TFEB inducers2026-06-30
▶研究关注：CDW reports in vivo results for LNP-LANFA2026-06-30
▶研究关注：Hzyg ligands disclosed in MSD patent2026-06-30
▶研究关注：Novel GPR52 agonist shows antipsychotic-like effects2026-06-30
▶研究关注：Yaoya Technology identifies new KRAS G12D mutant inhibitors2026-06-30
▶研究关注：Sichuan Kelun-Biotech discloses new KEAP1 activators and NRF2 degradation inducers2026-06-30
▶研究关注：Smartbax raises additional funds to advance antibiotic pipeline2026-06-30
▶研究关注：Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal2026-06-30
▶研究关注：Preclinical study of subpial AAV-GAD65/VGAT delivery for spinal injury-induced spasticity2026-06-30
▶研究关注：Blueprint Medicines reports new CDK4 degrader PROTACs2026-06-30
▶研究关注：Gensci-134: a long-acting growth hormone receptor agonist fusion protein2026-06-30
▶研究关注：Antibiotics spur protein transfer that boosts bacterial survival2026-06-30
▶研究关注：New Agentic Capabilities for Tasks Across the Complete Research Workflow2026-06-30
▶研究关注：Appointments and advancements for June 30, 20262026-06-30
▶研究关注：In the clinic for June 30, 20262026-06-30
▶研究关注：Financings for June 30, 20262026-06-30
▶研究关注：Other news to note for June 30, 20262026-06-30
▶研究关注：Regulatory actions for June 30, 20262026-06-30
▶研究关注：Two Proteins with Opposing Functions Found to Support Healthy Skin Maintenance2026-06-30
▶研究关注：Schistosomiasis Vaccine Shows Strong Immune Memory in Early Clinical Trials2026-06-29
▶研究关注：Iron Accumulation Drives Neurodegeneration via Chronic Stress Pathway2026-06-29
▶研究关注：Shilpa Commissions Integrated ADC Drug Substance GMP Manufacturing Facility2026-06-29
▶研究关注：CCRM Ireland Would Be Established to Hasten Translation of Advanced Therapies Into Patient Treatments2026-06-29
▶研究关注：The court said what it said, DC Circuit tells Norwich2026-06-29
▶研究关注：Zymeworks bolsters royalty stream with Theravance buy2026-06-29
▶研究关注：New Viridian meridian? Hopes veli high in TED post-FDA win2026-06-29
▶研究关注：Samsung Bioepis’ Keytruda biosimilar hits phase I, III endpoints2026-06-29
▶研究关注：Other news to note for June 29, 20262026-06-29
▶研究关注：Appointments and advancements for June 29, 20262026-06-29
▶研究关注：Financings for June 29, 20262026-06-29
▶研究关注：In the clinic for June 29, 20262026-06-29
▶研究关注：Regulatory actions for June 29, 20262026-06-29
▶研究关注：Roche launches Axelios 1 sequencing platform to rival Illumina2026-06-29
▶研究关注：EMA reverses its stance on Acadia’s Rett syndrome therapy Daybu2026-06-29
▶研究关注：Ascending BCI systems deepen national security, ethical concerns2026-06-29
▶研究关注：ICYMI: Week in review, June 22-26, 20262026-06-29
▶研究关注：Ascending BCI systems deepen national security, ethical concerns2026-06-29
▶研究关注：Biggest gainers and losers for June 22-26, 20262026-06-29
▶研究关注：Beijing Earthwise Technology discovers new E3 ligase/VAV1 interaction inducers2026-06-29
▶研究关注：Anti-HIV compounds reported in Boyuan Pharmaceutical patent2026-06-29
▶研究关注：Gensci-144 shows renoprotection in CKD2026-06-29
▶研究关注：Shandong Simcere Medgenn Bio-Pharmaceutical divulges new CDK4/cyclin D1 inhibitors2026-06-29
▶研究关注：Jiangxi Kerui Pharmaceutical patents new fungal GWT1 inhibitors2026-06-29
▶研究关注：Inhaled ALK5 inhibitor delivers lung-targeted antifibrotic effects2026-06-29
▶研究关注：Onco-Innovations evaluates ONC-010 in metabolism studies2026-06-29
▶研究关注：Sumitomo’s dual 5-HT2A/7 receptor antagonist counteracts dementia symptoms2026-06-29
▶研究关注：Changchun Genescience Pharmaceuticals discloses new VAV1 degradation inducers2026-06-29
▶研究关注：Ext1-targeted AAV gene therapy inhibits tau propagation in model of tauopathy2026-06-29
▶研究关注：IRAK4-targeting PROTAC degrader suppresses inflammatory signaling in vitro2026-06-29
▶研究关注：CINP 2026: Gut microbiota could predict antidepressant response2026-06-29
▶研究关注：TRIP13 blockade as a therapeutic approach in prostate cancer2026-06-29
▶研究关注：Theravance, after clinical setbacks, agrees to $929M buyout2026-06-29
▶研究关注：Tecan Integrates Agentic AI Into Its Introspect Lab Analytics Platform2026-06-29
▶研究关注：Celebrating recognition. Reaffirming our mission.2026-06-29
▶研究关注：10 clinical trials to watch in the second half of 20262026-06-29
▶研究关注：Insilico, SK Launch Up-to-$2.5B Neuroimmune AI Drug Collaboration2026-06-28
▶研究关注：Science fiction realized: BCI tech is here2026-06-28
▶研究关注：FDA says yes to Viridian’s Lumvoa in TED2026-06-28
▶Bionyra获1.65亿美元融资，进军炎症生物药2026-06-26
▶2026上半年生物制药融资盘点2026-06-26
▶生物制药融资额年度对比2026-06-26
▶CRISPR临床转化的关键拐点2026-06-26
▶膀胱内CAR-T疗法缩小膀胱癌2026-06-26
▶研究关注：BIO 2026: Alternatives to funding orphan drugs2026-06-26
▶生物医药行业人事变动速览2026-06-26
▶2026年6月26日生物医药简讯2026-06-26
▶2026年6月26日监管动态汇总2026-06-26
▶2026年6月26日临床动态汇总2026-06-26
▶2026年6月26日融资动态2026-06-26
▶5月多项III期试验报捷2026-06-26
▶强生双能量心腔消融技术登陆欧洲2026-06-26
▶大冢制药ADHD新药在合并焦虑试验中成功2026-06-26
▶EMA建议撤回安进Tavneos2026-06-26
▶《自然》撤回中国研究引信任危机2026-06-26
▶投资者押注脑机接口技术，应对神经疾病2026-06-26
▶FDA接受Replimune申请，态度转变2026-06-26
▶BIO大会聚焦中美生物技术合作监管紧张2026-06-26
▶抗体混合物完全保护仓鼠免受尼帕和亨德拉病毒感染2026-06-26
▶投资者押注变革性脑机接口技术治疗神经疾病2026-06-26
▶Alkermes新CEO计划挑战礼来和武田2026-06-26
▶Acadia药物二次申请获欧洲监管支持2026-06-26
▶Pharmgen Science发现新型H+/K+-ATP酶抑制剂2026-06-26
▶来纳医药公开新型WRN抑制剂2026-06-26
▶亚盛医药开发新型Bcl-xl降解诱导剂2026-06-26
▶Elixirgen与日本新药签署杜氏肌营养不良症mRNA疗法协议2026-06-26
▶上海英利制药发现新型KRAS突变抑制剂2026-06-26
▶Page公司开发新型蟾毒灵衍生物治疗转移性癌症2026-06-26
▶新型RIPK1抑制剂抗肝纤维化2026-06-26
▶Regeneron开发TSHR阻断抗体治疗Graves病2026-06-26
▶SEP-479临床前数据亮眼，甲状旁腺功能减退症新希望2026-06-26
▶靶向GPC3的ADC在肝癌模型中效果显著2026-06-26
▶Oblenio获6200万美元B轮融资推进三特异性抗体2026-06-26
▶Mwyngil GPR75反向激动剂展现抗肥胖潜力2026-06-26
▶胆固醇改写LDL清除规则2026-06-26
▶ENCALS 2026：基因研究推动ALS治疗新策略2026-06-26
▶Circio与Tcelltech合作开发下一代体内CAR-T和TCR-T细胞2026-06-26
▶AI框架发现多癌种CAR T新靶点2026-06-25
▶抗生素触发细菌间蛋白质共享2026-06-25
▶默克113亿美元收购Bio-Techne2026-06-25
▶BIO 2026：FDA领导层应对人才流失与中国竞争2026-06-25
▶PDUFA VIII谈判完成，行业预览协议要点2026-06-25
▶ACIP再因法院禁令取消会议2026-06-25
▶6月25日行业人事动态2026-06-25
▶2026年6月25日监管动态2026-06-25
▶2026年6月25日临床进展2026-06-25
▶2026年6月25日生物医药融资汇总2026-06-25
▶6月25日生物医药动态速览2026-06-25
▶Oblenio融资6200万美元推动三特异性抗体进入临床2026-06-25
▶新一代脑机接口公司接踵而至2026-06-25
▶H.B. Fuller 6.59亿英镑收购Advanced Medical Solutions2026-06-25
▶Ionis 获 FDA 批准扩大 Tryngolza 适应症2026-06-25
▶3.3亿美元B轮融资，中国原创药新模式崛起2026-06-25
▶默克113亿美元收购Bio-Techne2026-06-25
▶新一代脑机接口企业迎战挑战2026-06-25
▶Remix反向合并Passage Bio上市2026-06-25
▶Antares获诺华1.05亿美元合作开发抗癌药2026-06-25
▶BioWorld Science停刊通知2026-06-25
▶信达生物与Fortvita发现新型双受体激动剂2026-06-25
▶北卡罗来纳大学公开新型SLC7A5抑制剂2026-06-25
▶NS-035获日本孤儿药资格2026-06-25
▶墨尔本大学公开新型放射性药物专利2026-06-25
▶勃林格殷格翰发现新型mGlu3受体激动剂2026-06-25
▶默克雪兰诺携手Saturnus Bio攻克罕见心肌病2026-06-25
▶Combotope与勃林格殷格翰合作开发癌症抗体2026-06-25
▶意大利发现新型黄病毒抑制剂2026-06-25
▶新药GT-02897在多发性骨髓瘤临床前模型中展现疗效2026-06-25
▶BMS双靶CAR-T疗法展现抗骨髓瘤疗效2026-06-25
▶MJFF资助X-tosis推进帕金森病药物XTS-0012026-06-25
▶细胞外囊泡光免疫疗法靶向MDK阳性实体瘤2026-06-25
▶Ascletis 减肥新药 ASC-35 获 FDA 批准临床2026-06-25
▶RQ生物完成1.15亿美元A轮融资2026-06-25
▶优瑞科UX-DA003中美双获批临床2026-06-25
▶礼来19亿美元牵手和誉医药2026-06-25
▶AI揭示朊病毒蛋白潜力：抗生素新来源2026-06-25
▶InduPro获得Lonza先进生物共轭技术许可2026-06-25
▶新药靶向低密度脂蛋白受体通路控制胆固醇2026-06-24
▶Ionis新药获FDA扩大批准，迈入商业化转折点2026-06-24
▶亨廷顿病干细胞疗法首次人体试验启动2026-06-24
▶BIO 2026：CEO呼吁美国生物技术紧急行动2026-06-24
▶新型喂养细胞系大幅提升NK细胞产量2026-06-24
▶重编码大肠杆菌助力减肥药大规模生产2026-06-24
▶干细胞疗法制造规模化2026-06-24
▶WHO选定NIBRT为LMICs生物制药培训中心2026-06-24
▶Nuvectis与海思科达成14.6亿美元交易2026-06-24
▶平台技术知识产权增添疫苗研发挑战2026-06-24
▶WHO将宣布汉坦病毒疫情结束2026-06-24
▶Tissium获6000万欧元推进无缝合组织修复平台2026-06-24
▶Lilly与Abbisko达成19亿美元合作2026-06-24
▶Antares与诺华达成19亿美元合作，攻克不可成药癌症靶点2026-06-24
▶礼来GLP-1红利推动251亿美元并购狂潮2026-06-24
▶科信药业口服GLP-1激动剂2期肥胖临床达标2026-06-24
▶2026年6月24日行业人事变动2026-06-24
▶6月24日生物医药融资动态2026-06-24
▶2026年6月24日生物医药行业动态2026-06-24
▶2026年6月24日监管动态一览2026-06-24
▶6月24日临床快报2026-06-24
▶脑机接口问世，但前路漫漫2026-06-24
▶RQ Bio获1.15亿美元融资，研发长效防流感抗体2026-06-24
▶脑机接口已至，前路漫漫2026-06-24
▶迷幻药领域：竞争同行，实则同舟共济2026-06-24
▶Medra推出药物发现机器人推理层2026-06-24
▶聚焦RNA疗法新进展2026-06-24
▶肺部炎症揭示三种严重肺炎亚型2026-06-24
▶Sangamo破产拍卖，中国相关基因编辑初创获投2026-06-24
▶Ollin 获 3.3 亿美元推进 Vabysmo 挑战者关键试验2026-06-24
▶加州生命科学产业经济影响强劲2026-06-24
▶基因编辑先驱Sangamo申请破产，礼来与安斯泰来收购资产2026-06-24
▶严重肺炎分为三种亚型，或可指导个性化治疗2026-06-23
▶英伟达推出科学推理AI套件BioNeMo2026-06-23
▶新一代平台整合VectorBuilder与Maxcyte技术2026-06-23
▶辉瑞Seagen交易获的肺癌药研究失利2026-06-23
▶美推Operation Trailblazer加速早期药研2026-06-23
▶5月FDA批准24种药物，创2026年单月新高2026-06-23
▶辉瑞Seagen来源ADC在肺癌III期试验中失败2026-06-23
▶2026年6月23日行业人事变动2026-06-23
▶2026年6月23日生物医药融资盘点2026-06-23
▶生物医药周报：多领域合作与突破2026-06-23
▶2026年6月23日临床要闻2026-06-23
▶Croívalve获2700万美元推进三尖瓣修复设备2026-06-23
▶2026年6月23日全球监管动态2026-06-23
▶EFPIA报告：每1欧元新药投入带来5.67欧回报2026-06-23
▶Cynata干细胞疗法两项关键试验失败2026-06-23
▶麦科特拟港股IPO筹资12亿港元推进代谢疾病管线2026-06-23
▶J-Pharma LAT1抑制剂进入III期研究2026-06-23
▶SK生物制药与英矽智能达成25亿美元AI药物发现合作2026-06-23
▶2026年：脑机接口技术的转折点2026-06-23
▶中国率先批准实体瘤CAR-T疗法2026-06-23
▶2026年：脑机接口技术迎来关键转折点2026-06-23
▶Kardigan借MyoKardia遗资产逆袭IPO2026-06-23
▶HHS加速早期药物试验以应对中国崛起2026-06-23
▶K2斥资20亿美元获Antengene双特异性TCE资产2026-06-23
▶假期停刊通知2026-06-23
▶远见医疗发现新型环孢素类似物抗乙肝病毒2026-06-23
▶Zydus研发新型降脂药共晶体2026-06-23
▶豪森开发新型NK3受体拮抗剂2026-06-23
▶Opko 公布肢端肥大症新化合物数据2026-06-23
▶Rin研究所发现新型纤维蛋白靶向ADC2026-06-23
▶Lundbeck新药Lu-AG-22515在甲状腺眼病中展现潜力2026-06-23
▶杨森开发新型TMEM175激活剂2026-06-23
▶APOLD1变异与血管型出血性疾病关联2026-06-23
▶安宏医药获FDA批准开展AH-008临床2026-06-23
▶Matricelf启动神经组织植入物治疗脊髓损伤研究2026-06-23
▶肺炎分子分型揭示三种严重亚型2026-06-23
▶AAV基因疗法挽救Tay-Sachs眼部症状2026-06-23
▶Lys Therapeutics获资推进帕金森病新药2026-06-23
▶新型hPLA2-G5抑制剂展现镇痛抗炎潜力2026-06-23
▶人工智能助力抗击淋病2026-06-23
▶Cytomos展示AuraCyt数字预测细胞分析平台2026-06-23
▶BIO年会：生物技术IPO窗口开启但门槛提高2026-06-23
▶礼来停止340B折扣，医院大怒2026-06-23
▶亚太生物制药动态速览2026-06-23
▶亚太生物医药融资动态（2026年6月23日）2026-06-23
▶亚太生物医药监管动态：6月23日2026-06-23
▶亚太生物制药临床进展：2026年6月23日2026-06-23
▶长程基因网络发现641个精神分裂症新基因2026-06-23
▶AI发现新型抗菌“Prionin”肽2026-06-22
▶2026年6月22日行业简讯2026-06-22
▶欧洲医疗系统面临威胁，预防和创新是关键2026-06-22
▶最高法院审理PhRMA商业秘密披露挑战2026-06-22
▶Definium LSD疗法在重度抑郁症III期试验中脱颖而出2026-06-22
▶艾伯维109亿美元收购Apogee，强化免疫管线2026-06-22
▶生物医药行业最新人事任命2026-06-22
▶6月22日生物医药融资盘点2026-06-22
▶Cynata干细胞疗法两项关键试验失败2026-06-22
▶脑机接口终于来了？2026-06-22
▶Bionyra获1.65亿美元A轮融资，开发长效炎症抗体2026-06-22
▶2026年6月22日监管动态2026-06-22
▶6月22日临床动态：多家药企公布新数据2026-06-22
▶艾伯维109亿美元收购Apogee2026-06-22
▶Regenxbio将重新提交基因疗法申请2026-06-22
▶赛诺菲研发主管离职，默克免疫药物关键试验成功2026-06-22
▶一周回顾：6月15日至19日行业要闻2026-06-22
▶脑机接口时代来临？2026-06-22
▶BioWorld六月节放假通知2026-06-22
▶生物制药股票周涨跌榜出炉2026-06-22
▶脑浸润T细胞影响自闭症社交行为2026-06-22
▶母乳脂肪酸塑造小鼠免疫发育2026-06-22
▶浙江京科制药获新型sigma受体配体专利2026-06-22
▶Tennor Therapeutics发现新型抗菌药物2026-06-22
▶Brightgene合成新型GIPR/GCGR/GLP-1R三重激动剂2026-06-22
▶Evotec专利公开NLRP3炎症小体抑制剂前药2026-06-22
▶Asahi Kasei发现新型TNFR1拮抗剂2026-06-22
▶EVmiR-885-5p临床前模型显示可抑制三阴性乳腺癌扩散2026-06-22
▶ALN-CFB在PNH临床前研究中取得积极数据2026-06-22
▶Bioarctic与礼来合作研发神经退行性疾病新药2026-06-22
▶CATA-001双抗治疗轻链骨髓瘤初显成效2026-06-22
▶ETHY-001在临床前完全阻断TSHR2026-06-22
▶盖茨基金资助TB自我复制RNA疫苗开发2026-06-22
▶单剂mRNA疫苗抗击安第斯病毒2026-06-22
▶K2获Antengene两款双抗TCE许可，总价20亿美元2026-06-22
▶艾伯维近110亿美元收购Apogee，获长效自身免疫药物2026-06-22
▶Bionyra融资1.65亿美元开发免疫新药2026-06-22
▶专科药物早期干预：前14天决定成败2026-06-22

1 / 34

资讯专栏新闻资讯预印本研究权威期刊产业动态科研院所政府与政策

生态分类导航 X / Twitter support@biodir.net

© 2026 BioDir. 生物领域新闻与研究情报

Built with AI & @lazyxcode